I think if anything it could just influence Cytodyn to seek partnerships or strategic alliances to explore leronlimab to its full potential, rather than wait for NIH initiatives to align. Biotechs could also seek grants and deploy their research efforts in other countries.

I think for Cytodyn it’s full speed ahead!